These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 29602020)

  • 41. Blood-brain barrier (BBB) toxicity and permeability assessment after L-(4-¹⁰Boronophenyl)alanine, a conventional B-containing drug for boron neutron capture therapy, using an in vitro BBB model.
    Roda E; Nion S; Bernocchi G; Coccini T
    Brain Res; 2014 Oct; 1583():34-44. PubMed ID: 25128598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Murine in vitro model of the blood-brain barrier for evaluating drug transport.
    Shayan G; Choi YS; Shusta EV; Shuler ML; Lee KH
    Eur J Pharm Sci; 2011 Jan; 42(1-2):148-55. PubMed ID: 21078386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In silico modeling on ADME properties of natural products: Classification models for blood-brain barrier permeability, its application to traditional Chinese medicine and in vitro experimental validation.
    Zhang X; Liu T; Fan X; Ai N
    J Mol Graph Model; 2017 Aug; 75():347-354. PubMed ID: 28628860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug penetration across the blood-brain barrier: an overview.
    Mangas-Sanjuan V; González-Alvarez M; Gonzalez-Alvarez I; Bermejo M
    Ther Deliv; 2010 Oct; 1(4):535-62. PubMed ID: 22833966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of in vitro cell models in predicting in vivo brain entry of drugs.
    Hakkarainen JJ; Jalkanen AJ; Kääriäinen TM; Keski-Rahkonen P; Venäläinen T; Hokkanen J; Mönkkönen J; Suhonen M; Forsberg MM
    Int J Pharm; 2010 Dec; 402(1-2):27-36. PubMed ID: 20920560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.
    Pardridge WM; Triguero D; Yang J; Cancilla PA
    J Pharmacol Exp Ther; 1990 May; 253(2):884-91. PubMed ID: 2338660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 1. Anti-infective drugs.
    Adenot M; Perriere N; Scherrmann JM; Lahana R
    Chemotherapy; 2007; 53(1):70-2. PubMed ID: 17202814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Minimum Transendothelial Electrical Resistance Thresholds for the Study of Small and Large Molecule Drug Transport in a Human in Vitro Blood-Brain Barrier Model.
    Mantle JL; Min L; Lee KH
    Mol Pharm; 2016 Dec; 13(12):4191-4198. PubMed ID: 27934481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction.
    Summerfield SG; Read K; Begley DJ; Obradovic T; Hidalgo IJ; Coggon S; Lewis AV; Porter RA; Jeffrey P
    J Pharmacol Exp Ther; 2007 Jul; 322(1):205-13. PubMed ID: 17405866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methods to assess drug permeability across the blood-brain barrier.
    Nicolazzo JA; Charman SA; Charman WN
    J Pharm Pharmacol; 2006 Mar; 58(3):281-93. PubMed ID: 16536894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New experimental models of the blood-brain barrier for CNS drug discovery.
    Kaisar MA; Sajja RK; Prasad S; Abhyankar VV; Liles T; Cucullo L
    Expert Opin Drug Discov; 2017 Jan; 12(1):89-103. PubMed ID: 27782770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo, in vitro and in silico methods for small molecule transfer across the BBB.
    Mensch J; Oyarzabal J; Mackie C; Augustijns P
    J Pharm Sci; 2009 Dec; 98(12):4429-68. PubMed ID: 19408294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predict drug permeability to blood-brain-barrier from clinical phenotypes: drug side effects and drug indications.
    Gao Z; Chen Y; Cai X; Xu R
    Bioinformatics; 2017 Mar; 33(6):901-908. PubMed ID: 27993785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model.
    Roux GL; Jarray R; Guyot AC; Pavoni S; Costa N; Théodoro F; Nassor F; Pruvost A; Tournier N; Kiyan Y; Langer O; Yates F; Deslys JP; Mabondzo A
    Sci Rep; 2019 Nov; 9(1):16310. PubMed ID: 31690750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ionization-specific QSAR models of blood-brain penetration of drugs.
    Lanevskij K; Japertas P; Didziapetris R; Petrauskas A
    Chem Biodivers; 2009 Nov; 6(11):2050-4. PubMed ID: 19937840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of blood-brain barrier penetration: in silico, in vitro and in vivo.
    Feng MR
    Curr Drug Metab; 2002 Dec; 3(6):647-57. PubMed ID: 12369891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Demystifying brain penetration in central nervous system drug discovery. Miniperspective.
    Di L; Rong H; Feng B
    J Med Chem; 2013 Jan; 56(1):2-12. PubMed ID: 23075026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood Brain Barrier Permeability Prediction Using Machine Learning Techniques: An Update.
    Saxena D; Sharma A; Siddiqui MH; Kumar R
    Curr Pharm Biotechnol; 2019; 20(14):1163-1171. PubMed ID: 31433750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood-brain barrier structure and function and the challenges for CNS drug delivery.
    Abbott NJ
    J Inherit Metab Dis; 2013 May; 36(3):437-49. PubMed ID: 23609350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.